Ritu Soni

About

I am currently pursuing Ph.D. in Pharmacology from Institute of Pharmacy, Nirma University. I completed my masters in Pharmacology and Toxicology from NIPER-Ahmedabad. I have worked in Pharmacovigilance area in my previous job experience.

Employment

• APCER life sciences Pharmacovigilance associate
  2020 - 2021

Education

• Nirma University Institute of Pharmacy Ph.D.
  2021 - 2025
• National Institute of Pharmaceutical Education and Research M.S. Pharm
  2018 - 2020
• L.J. Institute of Pharmacy, GTU B.Pharm
  2014 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Ind…
  ACS Pharmacology & Translational Science 2026 DOI: 10.1021/acsptsci.6c00045
  +Save
• Upregulation of the PI3K/AKT and Nrf2 Pathways by the DPP-4 Inhibitor Sitagliptin Renders Neuroprotection in Chemically Induced Parkinson’s Disease Mouse Models
  ACS Chemical Neuroscience 2025 DOI: 10.1021/acschemneuro.5c00112
  +Save
• Dual GLP-1 and GIP Agonist Tirzepatide Exerted Neuroprotective Action in a Parkinson’s Disease Rat Model
  ACS Chemical Neuroscience 2025 DOI: 10.1021/acschemneuro.4c00729
  +Save
• Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson’s Disease-like Pathology in Mice
  ACS Pharmacology & Translational Science 2024 DOI: 10.1021/acsptsci.4c00586
  +Save
• Decoding the Role of Nuclear Sirtuins in Parkinson’s Pathogenesis
  ACS Chemical Neuroscience 2024 DOI: 10.1021/acschemneuro.4c00507
  +Save
• An update on new-age potential biomarkers for Parkinson’s disease
  Ageing Research Reviews 2024 DOI: 10.1016/j.arr.2024.102208
  +Save
• Uncovering Novel Therapeutic Targets for Parkinson’s Disease
  ACS Chemical Neuroscience 2023 DOI: 10.1021/acschemneuro.3c00084
  +Save
• Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 Secretion
  Molecular Neurobiology 2022 DOI: 10.1007/s12035-022-03071-3
  +Save
• Deciphering Intertwined Molecular Pathways Underlying Metabolic Syndrome Leading to Parkinson’s Disease
  ACS chemical neuroscience 2022 DOI: https://doi.org/10.1021/acschemneuro.2c00165
  +Save
• Association between Metabolic syndrome and Parkinson’s disease
  NIPICON-22 2022
  +Save